Alnylam Pharmaceuticals
Director, Business Development
Alnylam Pharmaceuticals, Cambridge, Massachusetts, us, 02140
OverviewAlnylam’s business strategy is to develop and commercialize a broad pipeline of RNAi therapeutic products directed towards our four Strategic Therapeutic Areas (STArs): Genetic Medicines, Cardio-Metabolic Diseases, Hepatic Infectious Diseases and CNS/Ocular Diseases. Business development has been and will continue to be an integral part of our short- and long-term growth strategy. We expect to enter into additional collaboration and licensing agreements as a means of obtaining resources, technologies, capabilities and funding to advance our investigational RNAi therapeutic programs.
The Director of Business Development will report to the Sr. Director of Business Development and will be a hybrid role based at Alnylam’s headquarters in Cambridge, MA.
Key ObjectivesLead the identification, evaluation and execution of acquisition, investment, and partnership opportunities across a range of therapeutic areas and assets, including:Out-licensing/in-licensing opportunitiesM&A opportunitiesResearch collaborations
Lead the negotiating and drafting of transaction term sheets and definitive agreements that utilize creative deal structures and processes that result in business success and maximum value.Support the execution of complex analytics to assess opportunities (e.g., comparable deal analysis and financial modeling/NPV analysis).Support the diligence activities for all transactions (e.g., preparing and setting up diligence files, financing documents, etc.).Partner closely with internal and external legal teams to negotiate and implement appropriate legal agreements to support research, development, and commercial goals.Support program and alliance management, finance and legal teams in transaction implementation and management.Support the development of a company strategy for maximum value creation and the development/refinement of a business/corporate development strategy that aligns with the company strategy.
QualificationsAn MBA (preferred, not required) with at least 7-10+ years of relevant industry experience in biotech/pharma business development, consulting, or investment banking. Must have an aptitude to quickly understand new science and technology.Proven interest in biotech/pharma.Demonstrated track record sourcing, prioritizing, diligencing, and significantly contributing and/or leading transactions to completion.Exceptional oral presentation and written communication skills; experience presenting to company executive management teams.Demonstrated strong analytical and financial modeling capabilities.Ability to work collaboratively with many different internal and external constituencies.Ability to manage multiple projects and tight timelines.Ability to interface with senior management internally and represent Alnylam with external parties.
About AlnylamAlnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the
RNAi Revolution
and continues to turn scientific possibility into reality.
Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2022, one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2023 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.
At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.
Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law. Alnylam is an E-Verify employer.
#J-18808-Ljbffr
The Director of Business Development will report to the Sr. Director of Business Development and will be a hybrid role based at Alnylam’s headquarters in Cambridge, MA.
Key ObjectivesLead the identification, evaluation and execution of acquisition, investment, and partnership opportunities across a range of therapeutic areas and assets, including:Out-licensing/in-licensing opportunitiesM&A opportunitiesResearch collaborations
Lead the negotiating and drafting of transaction term sheets and definitive agreements that utilize creative deal structures and processes that result in business success and maximum value.Support the execution of complex analytics to assess opportunities (e.g., comparable deal analysis and financial modeling/NPV analysis).Support the diligence activities for all transactions (e.g., preparing and setting up diligence files, financing documents, etc.).Partner closely with internal and external legal teams to negotiate and implement appropriate legal agreements to support research, development, and commercial goals.Support program and alliance management, finance and legal teams in transaction implementation and management.Support the development of a company strategy for maximum value creation and the development/refinement of a business/corporate development strategy that aligns with the company strategy.
QualificationsAn MBA (preferred, not required) with at least 7-10+ years of relevant industry experience in biotech/pharma business development, consulting, or investment banking. Must have an aptitude to quickly understand new science and technology.Proven interest in biotech/pharma.Demonstrated track record sourcing, prioritizing, diligencing, and significantly contributing and/or leading transactions to completion.Exceptional oral presentation and written communication skills; experience presenting to company executive management teams.Demonstrated strong analytical and financial modeling capabilities.Ability to work collaboratively with many different internal and external constituencies.Ability to manage multiple projects and tight timelines.Ability to interface with senior management internally and represent Alnylam with external parties.
About AlnylamAlnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the
RNAi Revolution
and continues to turn scientific possibility into reality.
Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2022, one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2023 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.
At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.
Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law. Alnylam is an E-Verify employer.
#J-18808-Ljbffr